Lexicon Pharmaceuticals (United States)
In research, Lexicon Pharmaceuticals (United States) stands highest in Life Sciences (#7,113 of 11,023 worldwide), Health Sciences (#12,331 of 16,688 worldwide) and Medicine (#10,872 of 14,558 worldwide), over all time.
- World rank, 2022-now
- #19,689 of 22,385 · #16,699 all time
- Rank in United States
- #2,914 of 3,332
- Research works
- 565 ▼ 27% vs 2018-21
- Citations
- 18k 31.3 per fractional work
- Top-10% rate
- 5.6% all institutions 10.0%
- vs its own fields
- 0.97× 1.00× is exactly expected
- Open access
- 50% world 40%
- International
- 20% world 18%
What is Lexicon Pharmaceuticals (United States) known for in research?
The fields where it stands highest, over all time, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works |
|---|---|---|---|---|
| Life SciencesDomain | #7,113 of 11,023 | 14.2% | 142 | |
| Health SciencesDomain | #12,331 of 16,688 | 16.1% | 137 | |
| MedicineField | #10,872 of 14,558 | 16.9% | 124 | |
| Social SciencesDomain | #13,263 of 14,833 | 10.0% | 145 | |
| Physical SciencesDomain | #17,086 of 17,446 | 5.8% | 141 |
Each strip is that field's whole ranked pool, with the notch where Lexicon Pharmaceuticals (United States) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no average mark, because the average differs by field (from about 6% in Dentistry to 21% in Economics).
Which fields of science does Lexicon Pharmaceuticals (United States) work in?
In 2022-now, 43% of research at Lexicon Pharmaceuticals (United States) is in Social Sciences, 25% in Health Sciences. Its largest fields are Medicine (23%), Social Sciences (20%), Computer Science (18%). It does 1.7× the world's share of Social Sciences.
Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.
Its 4 domains and 22 fields, with their numbers
- Social Sciences4443.3%
- Social Sciences2019.8%
- Arts and Humanities1312.5%
- Business, Management and Accounting44.0%
- Economics, Econometrics and Finance43.9%
- Psychology32.8%
- Decision Sciences00.3%
- Health Sciences2524.8%
- Medicine2423.5%
- Health Professions10.9%
- Nursing00.5%
- Physical Sciences2322.4%
- Computer Science1918.4%
- Engineering32.6%
- Environmental Science10.6%
- Physics and Astronomy00.3%
- Chemistry00.2%
- Materials Science00.1%
- Mathematics00.1%
- Earth and Planetary Sciences00.1%
- Life Sciences109.4%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Arts and Humanities, 4.3×. Every wedge is a field page.
All 22 fields, with their numbers
- Arts and Humanities4.33×13 works
- Computer Science2.36×18 works
- Economics, Econometrics and Finance1.84×4 works
- Social Sciences1.56×20 works
- Neuroscience1.51×2 works
- Business, Management and Accounting1.23×4 works
- Medicine1.22×24 works
- Biochemistry, Genetics and Molecular Biology1.10×6 works
- Nursing1.01×0 works
- Psychology0.93×3 works
- Pharmacology, Toxicology and Pharmaceutics0.37×0 works
- Health Professions0.33×1 works
- Decision Sciences0.28×0 works
- Agricultural and Biological Sciences0.20×1 works
- Engineering0.17×3 works
- Physics and Astronomy0.15×0 works
- Environmental Science0.12×1 works
- Chemistry0.11×0 works
- Mathematics0.11×0 works
- Immunology and Microbiology0.05×0 works
- Earth and Planetary Sciences0.04×0 works
- Materials Science0.04×0 works
- Arts and Humanities 4.3×
- Computer Science 2.4×
- Economics, Econometrics and Finance 1.8×
- Social Sciences 1.6×
- Neuroscience 1.5×
- Business, Management and Accounting 1.2×
- Medicine 1.2×
- Biochemistry, Genetics and Molecular Biology 1.1×
- Nursing 1.0×
- Psychology 0.9×
- Pharmacology, Toxicology and Pharmaceutics 0.4×
- Health Professions 0.3×
- Decision Sciences 0.3×
- Agricultural and Biological Sciences 0.2×
- Engineering 0.2×
- Physics and Astronomy 0.1×
- Environmental Science 0.1×
- Chemistry 0.1×
- Mathematics 0.1×
- Immunology and Microbiology 0.1×
- Earth and Planetary Sciences 0.0×
- Materials Science 0.0×
Who are the top researchers at Lexicon Pharmaceuticals (United States)?
Ranked on the quality score, Brian Zambrowicz, Arthur Sands and Phillip Lee Banks lead among researchers whose main affiliation is Lexicon Pharmaceuticals (United States).
- 1
Brian Zambrowicz
United States · #35,149 worldwide 14k citations · 144 works
- 2
Arthur Sands
United States · #115,650 worldwide 9.6k citations · 86 works
- 3
Phillip Lee Banks
United States · #172,189 worldwide 4.1k citations · 106 works
- 4
David R. Powell
United States · #187,650 worldwide 4k citations · 53 works
- 5
Brian D. Hamman
United States · #284,898 worldwide 4.1k citations · 39 works
- 6
Kenneth A. Platt
United States · #328,860 worldwide 6.3k citations · 46 works
- 7
Dennis S. Rice
United States · #457,579 worldwide 6.7k citations · 85 works
- 8
Robert Brommage
United States · #523,707 worldwide 5.9k citations · 117 works
- 9
Gwenn M. Hansen
United States · #581,079 worldwide 3.1k citations · 65 works
- 10
Pablo Lapuerta
United States · #654,055 worldwide 11k citations · 201 works
Which keywords describe research at Lexicon Pharmaceuticals (United States)?
By fractional works in 2022-now, weighted toward what it does more of than the world: Artificial Intelligence, Heart Failure, Big Data, Machine Learning, Glycemic Control, Insulin Therapy, Ethics and Neural Networks.
- Topic Modeling
- Language Variation
- Language Contact
- Terminology
- Ontologies
- International Law
- Sociolinguistics
- Usage
- Bilingualism
- History
- Cardiovascular Disease
- Language
- Algorithmic Bias
- Surveillance
- Glucose Control
- Type 2 Diabetes
- Deep Learning
- Insulin Therapy
- Heart Failure
- Artificial Intelligence
- Machine Learning
- Big Data
- Glycemic Control
- Neural Networks
- Ethics
- Cardiovascular Outcomes
- Lexicography
- Fairness
- Transparency
- Corpus Linguistics
- Dictionaries
- Language Teaching
- Electronic
- Knowledge Representation
- Diabetes
- Pragmatics
- Specialized Language
- Ethical Implications
- Phraseology
- Text Classification
Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Machine Learning11▲ 3.3×15 topics
- Artificial Intelligence10▲ 6.7×9 topics
- Big Data8▲ 7.8×8 topics
- Heart Failure8▲ 17×7 topics
- Glycemic Control7▲ 43×3 topics
- Insulin Therapy7▲ 54×3 topics
- Neural Networks7▲ 4.4×11 topics
- Deep Learning6▲ 1.73×15 topics
- Ethics6▲ 11×6 topics
- Type 2 Diabetes5▲ 23×3 topics
- Cardiovascular Outcomes5▲ 87×1 topic
- Glucose Control5▲ 87×1 topic
- Lexicography5▲ 57×3 topics
- Surveillance5▲ 16×2 topics
- Fairness4▲ 42×2 topics
- Algorithmic Bias4▲ 50×1 topic
- Transparency4▲ 30×1 topic
- Language4▲ 17×5 topics
- Corpus Linguistics4▲ 19×4 topics
- Cardiovascular Disease4▲ 3.2×9 topics
- Dictionaries3▲ 109×2 topics
- History3▲ 4.4×3 topics
- Language Teaching3▲ 11×4 topics
- Bilingualism3▲ 21×4 topics
- Electronic3▲ 162×1 topic
- Usage3▲ 162×1 topic
- Knowledge Representation3▲ 32×4 topics
- Sociolinguistics3▲ 15×5 topics
- Diabetes3▲ 5.2×8 topics
- International Law3▲ 8.4×6 topics
- Pragmatics3▲ 17×3 topics
- Ontologies2▲ 41×2 topics
- Specialized Language2▲ 123×1 topic
- Terminology2▲ 100×1 topic
- Ethical Implications2▲ 39×2 topics
- Language Contact2▲ 22×3 topics
- Phraseology2▲ 28×3 topics
- Language Variation2▲ 34×3 topics
- Text Classification2▲ 12×2 topics
- Topic Modeling2▲ 12×2 topics
Which research topics does Lexicon Pharmaceuticals (United States) publish most on?
By volume in 2022-now: Diabetes Treatment and Management, Ethics and Social Impacts of AI, Lexicography and Language Studies and linguistics and terminology studies.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Diabetes Treatment and Management Endocrinology, Diabetes and Metabolism 5 works
- 2 Ethics and Social Impacts of AI Safety Research 4 works
- 3 Lexicography and Language Studies Language and Linguistics 3 works
- 4 linguistics and terminology studies Language and Linguistics 2 works
- 5 Topic Modeling Artificial Intelligence 2 works
- 6 Adversarial Robustness in Machine Learning Artificial Intelligence 2 works
- 7 Spanish Linguistics and Language Studies Language and Linguistics 2 works
- 8 Cybersecurity and Cyber Warfare Studies Political Science and International Relations 2 works
- 9 Natural Language Processing Techniques Artificial Intelligence 2 works
- 10 Speech and Audio Processing Signal Processing 1 works
How open and international is its research?
Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 40% of research is openly available.
World: 18% is written across borders.
How has Lexicon Pharmaceuticals (United States)'s research output changed?
Output in 2022-2025 was 27% lower than in 2018-2021.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is Lexicon Pharmaceuticals (United States) as a percentage of every work published that year, 0.00034% in 2024.
Fractional works of Lexicon Pharmaceuticals (United States) over all fractional works that year. How the balance of science has shifted.
How much of it reaches the world top 10%
Year by year, against all institutions in the same year.
Of each year's output, the share that reached the world's 10% most cited for its field and year. Peak 14.9% in 2010.
Other research institutions in The Woodlands
- Huntsman (United States)
- Houston Advanced Research Center
- The US Oncology Network
- Opexa Therapeutics (United States)
- Chevron Phillips Chemical (United States)
- EpiCypher (United States)
- American Society of Pediatric Nephrology
- Sigma Genosys (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.
Discussion
Ask a question or share a note about Lexicon Pharmaceuticals (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.
